111 Capital Invests $340,000 in Plexus Corp. $PLXS

111 Capital bought a new position in shares of Plexus Corp. (NASDAQ:PLXS) in the 2nd quarter, Holdings Channel reports. The fund bought 2,510 shares of the technology company’s stock, valued at approximately $340,000.

Several other hedge funds have also made changes to their positions in PLXS. Fuller & Thaler Asset Management Inc. boosted its stake in shares of Plexus by 120.4% during the first quarter. Fuller & Thaler Asset Management Inc. now owns 348,510 shares of the technology company’s stock worth $44,655,000 after buying an additional 190,360 shares during the period. Nuveen LLC acquired a new stake in shares of Plexus during the first quarter worth about $22,975,000. American Century Companies Inc. boosted its stake in shares of Plexus by 24.7% during the first quarter. American Century Companies Inc. now owns 678,222 shares of the technology company’s stock worth $86,901,000 after buying an additional 134,205 shares during the period. Millennium Management LLC boosted its stake in shares of Plexus by 85.1% during the first quarter. Millennium Management LLC now owns 228,116 shares of the technology company’s stock worth $29,229,000 after buying an additional 104,904 shares during the period. Finally, Invesco Ltd. boosted its stake in shares of Plexus by 66.1% during the first quarter. Invesco Ltd. now owns 211,741 shares of the technology company’s stock worth $27,130,000 after buying an additional 84,249 shares during the period. Institutional investors and hedge funds own 94.45% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on PLXS shares. Wall Street Zen downgraded shares of Plexus from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 16th. Sidoti upgraded shares of Plexus from a “neutral” rating to a “buy” rating and increased their target price for the stock from $135.00 to $150.00 in a research note on Friday, July 25th. Needham & Company LLC cut their price target on shares of Plexus from $162.00 to $158.00 and set a “buy” rating for the company in a report on Thursday, July 24th. Benchmark increased their price target on shares of Plexus from $160.00 to $165.00 and gave the stock a “buy” rating in a report on Monday, September 22nd. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of Plexus in a report on Saturday, September 27th. Three research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $155.60.

Insiders Place Their Bets

In other news, CFO Patrick John Jermain sold 2,500 shares of the stock in a transaction that occurred on Wednesday, August 27th. The shares were sold at an average price of $137.71, for a total value of $344,275.00. Following the sale, the chief financial officer directly owned 20,959 shares in the company, valued at $2,886,263.89. This represents a 10.66% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Oliver K. Mihm sold 2,102 shares of the stock in a transaction that occurred on Friday, August 15th. The shares were sold at an average price of $130.43, for a total transaction of $274,163.86. Following the completion of the sale, the chief operating officer owned 21,155 shares in the company, valued at $2,759,246.65. This represents a 9.04% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 15,856 shares of company stock valued at $2,142,440. Corporate insiders own 1.76% of the company’s stock.

Plexus Trading Up 2.5%

Shares of Plexus stock opened at $148.85 on Tuesday. Plexus Corp. has a 12-month low of $103.43 and a 12-month high of $172.89. The company has a current ratio of 1.58, a quick ratio of 0.74 and a debt-to-equity ratio of 0.06. The stock has a market cap of $4.02 billion, a PE ratio of 25.36 and a beta of 0.80. The company has a 50-day moving average of $136.53 and a two-hundred day moving average of $131.87.

Plexus (NASDAQ:PLXS) last issued its earnings results on Wednesday, July 23rd. The technology company reported $1.90 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.71 by $0.19. Plexus had a net margin of 4.04% and a return on equity of 12.33%. The company had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $1.02 billion. During the same period last year, the company posted $1.45 earnings per share. The firm’s quarterly revenue was up 6.0% compared to the same quarter last year. Plexus has set its Q4 2025 guidance at 1.820-1.970 EPS. On average, research analysts anticipate that Plexus Corp. will post 5.9 EPS for the current fiscal year.

Plexus Company Profile

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.